January 1, 2014|
January 2014's selection of notable quotes
December 12, 2013|
Consumers, patients, and study participants should be made aware of potential incidental findings, according to a federally-appointed bioethics panel.
December 4, 2013|
Shortly after getting in trouble with the Food and Drug Administration, the personal genetic testing company is slapped with a class action lawsuit.
November 26, 2013|
The US Food and Drug Administration blocks the marketing of unapproved genetic tests.
November 20, 2013|
Conflicting clinical trial results leave researchers unsure whether genetic information is useful for determining initial Warfarin dosage.
September 5, 2013|
An NIH program will study the promises and pitfalls of sequencing newborns’ genomes.
July 11, 2013|
Myriad Genetics, the company originally behind tests for the cancer-associated BRCA mutations, is suing two competitors for patent infringement.
July 10, 2013|
A baby has been born using in vitro fertilization aided by next-generation sequencing of embryos for genetic abnormalities.
May 7, 2013|
Experts disagree on how doctors should reveal incidental findings in patients’ DNA sequences.
July 19, 2012|
James Watson files a brief in the ongoing legal case over Myriad Genetics’ right to hold patents on the BRCA1 and BRCA2 genes.